Accure Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Accure Therapeutics?

Accure Therapeutics has 5 investors including Michael J. Fox Foundation And Luxembourg National Research Fund.

Q: How much funding has Accure Therapeutics raised to date?

Accure Therapeutics has raised obfuscated.

Overview

Accure Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Accure Therapeutics

CB Rank

57967

Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.

Founded

obfuscation

Private

Grant

Barcelona, Catalonia, Spain

11-50

accure.health/

Biotechnology

Health Care

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Laurent Nguyen Cong Duc: Co-Founder & Chief Executive Officer
Past Role: Sensorion, CEO
Roger Prades: Project Director
Past Role: Iproteos, Chief Scientific Officer

Details

Legal Name

Accure Therapeutics S.L.

Operating Status

Active

Company Type

For Profit

Founders

Laurent Nguyen Cong Duc, Pablo Villoslada

About the Company

Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.

Phone Number

+34 93 125 86 07

Contact Email

info@accure.health

Predictions & Insights

Growth Insight

See this Growth Insight

Accure Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

ACT-02

A selective inhibitor of Prolyl Endopeptidase (PREP) designed to reduce alpha-synuclein aggregation and improve mitochondrial function in Parkinson’s disease models.

ACT-03

A selective matrix metalloproteinase (MMP) inhibitor that demonstrates anti-epileptogenic activity and cognitive protection in epilepsy models.

Research & Development

Accure Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant
obfuscated obfuscation	Grant - Accure Therapeutics	2	obfuscated obfuscation	Michael J. Fox Foundation	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Michael J. Fox Foundation	Yes	Grant - Accure Therapeutics	—
Michael J. Fox Foundation	Yes	Grant - Accure Therapeutics	—
Michael J. Fox Foundation	Yes	Grant - Accure Therapeutics	—
Michael J. Fox Foundation	Yes	Grant - Accure Therapeutics	—
Michael J. Fox Foundation	Yes	Grant - Accure Therapeutics	—

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Board Members and Advisors

Contacts

Employee Profiles

Laurent Nguyen Cong Duc Co-Founder & Chief Executive Officer
Roger Prades Project Director
Pablo Villoslada Co-Founder, Chief Scientific Officer & Chairman of Scientific Advisory Board